1365212-65-2Relevant academic research and scientific papers
Development of subnanomolar radiofluorinated (2-pyrrolidin-1-yl)imidazo[1,2-b]pyridazine pan-Trk inhibitors as candidate PET imaging probes
Bernard-Gauthier, Vadim,Bailey, Justin J.,Aliaga, Arturo,Kostikov, Alexey,Rosa-Neto, Pedro,Wuest, Melinda,Brodeur, Garrett M.,Bedell, Barry J.,Wuest, Frank,Schirrmacher, Ralf
, p. 2184 - 2193 (2015/12/11)
Dysregulation of tropomyosin receptor kinases (TrkA/B/C) expression and signalling is recognized as a hallmark of numerous neurodegenerative diseases including Parkinson's, Huntington's and Alzheimer's disease. TrkA/B/C is known to drive tumorogensis and
COMPOUNDS AND COMPOSITIONS AS TRK INHIBITORS
-
Page/Page column 55, (2012/03/27)
The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated TRK kinase activity.
